AdnaGen Newsletter

20th November

Molecular Characterization: A differentiating factor of the Alere™ CTC AdnaTest for companion diagnosis

The molecular characterization of CTCs will provide important information for identification of therapeutic targets for understanding resistance to therapies. It also should offer new insights into the biology of tumor dormancy and tumor cell dissemination. This will open new opportunities for the early detection of metastatic spread and its successful treatment.


More info about circulating tumor cell testing with TATAA